Dr Reddy’s Labs Q3 Results: Dr Reddy’s Laboratories on Wednesday, January 21, posted a 14% decline in the consolidated net profit during the third quarter of the financial year 2025-26 (Q3FY26).
The pharma major, part of the Nifty 50 index, said its net profit stood at ₹1209.8 crore in Q3 FY26 as against ₹1413.3 crore in the same period a year ago. However, analysts, on average, had estimated profit to fall to ₹1070 crore, as per data compiled by LSEG, showed a reuters report.
Its revenue from operations rose 4.4% to ₹8726.8 crore in the quarter under review compared with ₹8358.6 crore in Q3FY25.
